HomeGLENMARK • NSE
add
Glenmark Pharmaceuticals Ltd
Nakaraang pagsara
₹1,406.40
Sakop ng araw
₹1,378.10 - ₹1,444.00
Sakop ng taon
₹985.20 - ₹1,830.95
Market cap
396.59B INR
Average na Volume
691.83K
P/E ratio
-
Dividend yield
0.18%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 33.88B | 35.14% |
Gastos sa pagpapatakbo | 18.26B | -0.24% |
Net na kita | 3.48B | 199.03% |
Net profit margin | 10.27 | 173.25% |
Kita sa bawat share | 20.73 | — |
EBITDA | 5.73B | 302.61% |
Aktuwal na % ng binabayarang buwis | 23.73% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 18.20B | 61.94% |
Kabuuang asset | — | — |
Kabuuang sagutin | — | — |
Kabuuang equity | 84.45B | — |
Natitirang share | 282.21M | — |
Presyo para makapag-book | 2.35 | — |
Return on assets | — | — |
Return on capital | 11.67% | — |
Cash Flow
Net change in cash
| (INR) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 3.48B | 199.03% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Glenmark Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Wikipedia
Itinatag
Nob 18, 1977
Website
Mga Empleyado
14,989
